Arovella has raised $12.5m to advance its lead product, ALA-101, into phase 1 first-in-human clinical trials.
• Specifically, funds raised will be used to:
• Complete GMP manufacture of ALA-101 for phase 1
• Complete IND-enabling non-clinical safety and efficacy studies to support a phase 1 study in CD19+ B cell malignancies
• Commence and advance phase 1 clinical trial for ALA-101 and generate human data
• Continue development of additional pipeline products including ALA-105, IL-12-TM and future partnerships Offer Details
• $12.5 million Placement (“Placement”.
• The Offer was priced at $0.10 per New Share (“Offer Price”, which represents a:
• 23.1% discount to last close on 21 March 2024
• The Offer includes a 1-for-1 attaching Option with an exercise price of $0.15 and an expiry date of 3 years from date of issue.
• As at 31 December 2023, Arovella had net cash of $4.8 million. Post the offer, the Company will have a pro-forma cash balance (net of offer costs) of approximately $16.5 million. The Company also expects an R&D Tax Incentive receivable for FY24 of ~$3.5 million to be received in Q4 2024.
------------------------------------------------------------------------------------------------------
$12.5 million fair whack of cash, but guess it'll get joint a long way down road and by then we will know what we know.
- Forums
- ASX - By Stock
- ALA
- Ann: Investor Presentation
Ann: Investor Presentation, page-2
Featured News
Add ALA (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $126.0M |
Open | High | Low | Value | Volume |
12.0¢ | 12.0¢ | 11.0¢ | $78.33K | 678.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 565311 | 11.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.0¢ | 1333348 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 565311 | 0.110 |
13 | 543011 | 0.105 |
19 | 915451 | 0.100 |
1 | 10000 | 0.099 |
3 | 1015001 | 0.098 |
Price($) | Vol. | No. |
---|---|---|
0.120 | 1333348 | 9 |
0.125 | 445027 | 7 |
0.130 | 278751 | 5 |
0.135 | 20780 | 1 |
0.140 | 651732 | 12 |
Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
Last
11.5¢ |
  |
Change
0.000 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
11.8¢ | 12.0¢ | 11.5¢ | 189773 | ||
Last updated 15.12pm 21/05/2024 ? |
Featured News
ALA (ASX) Chart |
The Watchlist
AUQ
ALARA RESOURCES LIMITED
Stephen Gethin, Non-Executive Director & Chairman
Stephen Gethin
Non-Executive Director & Chairman
Previous Video
Next Video
SPONSORED BY The Market Online